Product approvals

Orange Man, Brian McKee, delivers care packages to individuals who are isolating, to celebrate the 12th of July as traditional large-scale parades were cancelled this year due to the pandemic, in east Belfast, Monday, July 13, 2020. The Twelfth is being celebrated on 13 July as 12 July this year fell on a Sunday, to mark the anniversary of the victory of Protestant William of Orange over Catholic King James II at the Battle of the Boyne in July 1690. (Niall Carson/PA via AP)
1010 WINS Newsroom
July 13, 2020 - 4:04 pm
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Monday related to the national and global response, the work place and the spread of the virus. ________________________ FRONT LINE VIRUS COMPANIES: — Two vaccine candidates...
Read More
Emiratis wearing face masks due to the coronavirus pandemic work on the floor of the Dubai Financial Market in Dubai, United Arab Emirates, Tuesday, July 7, 2020. Dubai reopened its Dubai Financial Market stock exchange Tuesday after closing its floor due to the coronavirus pandemic. (AP Photo/Jon Gambrell)
1010 WINS Newsroom
July 07, 2020 - 12:07 pm
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Tuesday related to the national and global response, the work place and the spread of the virus. ________________________ FOOD & SHOPPING: — Overall retail sales are...
Read More
FILE - In this Aug. 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building is visible behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday, June 15, 2020, the game built by Boston-based Akili Interactive Labs can improve attention function. (AP Photo/Jacquelyn Martin, File)
1010 WINS Newsroom
June 15, 2020 - 7:17 pm
BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx,...
Read More
This May 2020 photo shows Phexxi, a contraceptive made by San Diego-based Evofem Bioscience. The Food and Drug Administration on Friday, May 22, 2020 approved the new contraceptive. (Christine Blackburne via AP)
1010 WINS Newsroom
May 22, 2020 - 2:53 pm
U.S. regulators on Friday approved a birth control gel that works in a new way to prevent pregnancy. Phexxi comes in an applicator that women insert before sex. The gel made by San Diego-based Evofem Biosciences contains lactic acid, citric acid and potassium bitartrate, all of which are common...
Read More
FILE - In this Thursday, Jan. 2, 2020 file photo, vaping devices are displayed at a store in New York. On Thursday, April 23, 2020, the U.S. Food and Drug Administration said that a federal court accepted its request to push back the May 12 deadline to submit vaping product applications to Sept. 9. The agency said the COVID-19 pandemic has delayed preparations to meet the deadline for both companies and FDA staff. (AP Photo/Mary Altaffer)
1010 WINS Newsroom
April 23, 2020 - 2:57 pm
WASHINGTON (AP) — Electronic cigarette companies will have four additional months to submit their products for government review because of delays tied to the coronavirus outbreak. The Food and Drug Administration said Thursday that a federal court accepted its request to push back the May 12...
Read More
In this April 3, 2020, photo, blue preservation solution is shown at Spectrum DNA in Draper, Utah. The company has developed a test kit to detect the coronavirus in patients' saliva. At least two Utah companies have developed tests and gotten emergency authorization from the U.S. Food and Drug Administration: molecular diagnostics company Co-Diagnostics and ancestry-testing kit maker Spectrum DNA. (AP Photo/Rick Bowmer)
1010 WINS Newsroom
April 13, 2020 - 4:52 pm
WASHINGTON (AP) — Rutgers University researchers have received U.S. government clearance for the first saliva test to help diagnose COVID-19, a new approach that could help expand testing options and reduce risks of infection for health care workers. The Food and Drug Administration authorized the...
Read More
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
1010 WINS Newsroom
March 24, 2020 - 9:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More
This undated photo provided by Esperion Inc. shows the cholesterol-lowering drug Nexletol made by Esperion Therapeutics Inc. The Food and Drug Administration on Friday, Feb. 21, 2020 approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and others who have heart disease and need to further lower their bad cholesterol.(Esperion Inc. via AP)
1010 WINS Newsroom
February 21, 2020 - 4:41 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s...
Read More
In this Nov. 5, 2019 photo, in St. Francis, Wis., Amy Carter looks at her Yorkshire terrier-Chihuahua mix Bentley, who has epilepsy. Carter, gives him CBD, which she says has reduced his seizures. The federal government has yet to establish standards for CBD that will help pet owners know whether it works and how much to give. But the lack of regulation has not stopped some from buying it, fueling a $400 million CBD market for pets that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group. (AP Photo/Carrie Antlfinger)
1010 WINS Newsroom
January 07, 2020 - 11:43 am
Companies have unleashed hundreds of CBD pet health products accompanied by glowing customer testimonials claiming the cannabis derivative produced calmer, quieter and pain-free dogs and cats. But some of these products are all bark and no bite. “You'd be astounded by the analysis we've seen of...
Read More
This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Friday, Dec. 13, 2019, U.S. regulators approved expanded use of the medication for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. (Amarin via AP)
1010 WINS Newsroom
December 13, 2019 - 5:53 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was approved years ago for people with sky-high triglycerides, a type of fat in blood...
Read More

Pages